---
title: "AYJK released its performance for the first three quarters, with a net profit attributable to the parent company of 40.1137 million yuan, a year-on-year increase of 3.71%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263478784.md"
description: "According to the Zhitong Finance APP, AYJK released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.36 billion yuan, a year-on-year decrease of 9.39%. The net profit attributable to shareholders of the listed company was 40.1137 million yuan, a year-on-year increase of 3.71%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 32.0285 million yuan, a year-on-year decrease of 10.61%"
datetime: "2025-10-30T09:58:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263478784.md)
  - [en](https://longbridge.com/en/news/263478784.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263478784.md)
generator: "portal-rs"
---

# AYJK released its performance for the first three quarters, with a net profit attributable to the parent company of 40.1137 million yuan, a year-on-year increase of 3.71%

According to the Zhitong Finance APP, AYJK (002172.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 1.36 billion yuan, a year-on-year decrease of 9.39%. The net profit attributable to shareholders of the listed company was 40.1137 million yuan, a year-on-year increase of 3.71%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 32.0285 million yuan, a year-on-year decrease of 10.61%

### Related Stocks

- [002172.CN](https://longbridge.com/en/quote/002172.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [JDC: Record growth in turnover and EBITDA, with strong outlook driven by new regulation and AI](https://longbridge.com/en/news/296247395.md)
- [Demant hearing care chief Niels Wagner sells shares worth DKK 1.47 million](https://longbridge.com/en/news/296345010.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**